<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02196389</url>
  </required_header>
  <id_info>
    <org_study_id>Dec2013</org_study_id>
    <nct_id>NCT02196389</nct_id>
  </id_info>
  <brief_title>Comparison Between 4 Different Nasal Dilators</brief_title>
  <official_title>Comparison Between 4 Different Nasal Dilators: Objective vs Subjective Parameters</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Several nasal dilators are currently commercially available, and can be applied endonasally
      (Airmax°, Nozovent and Nasanita°) or externally (Breath Right°). An objective comparison
      between these dilators has not been made so far, and would help the clinicians to advise the
      use of any of these dilators. From clinical experience, endonasal dilators are well supported
      and improve breathing better than the external dilators
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Several nasal dilators are currently commercially available, and can be applied endonasally
      (Airmax°, Nozovent and Nasanita°) or externally (Breath Right°). An objective comparison
      between these dilators has not been made so far,
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Peak Nasal Inflammatory Flow</measure>
    <time_frame>4 weeks</time_frame>
    <description>Change in Peak Nasal Inflammatory Flow between the 4 different dilators</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>preference</measure>
    <time_frame>4 weeks</time_frame>
    <description>Patients' preference of 2 out of 4 dilators tested at baseline for a trial period of 4 week duration.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>surgery</measure>
    <time_frame>4 weeks</time_frame>
    <description>Patients' preference to continue to use the preferred dilator after the 4 weeks' trial period or choice to undergo surgery after one month of usage of the preferred dilator.</description>
  </other_outcome>
  <other_outcome>
    <measure>reasons of choice</measure>
    <time_frame>4 weeks</time_frame>
    <description>Specific reasons for the choice of the two dilators at baseline (functional vs aesthetic) at baseline</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Incompetence of Nasal Valve</condition>
  <arm_group>
    <arm_group_label>Nozovent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nasal Dilator</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nasanita</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nasal Dilator</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Breath Right</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nasal Dilator</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Airmax</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nasal Dilator</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nasal dilator Nasanita</intervention_name>
    <description>Nasal Dilator</description>
    <arm_group_label>Nasanita</arm_group_label>
    <other_name>Nasanita</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nasal dilator Nozovent</intervention_name>
    <arm_group_label>Nozovent</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nasal dilator Breath Right</intervention_name>
    <arm_group_label>Breath Right</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nasal dilator Airmax</intervention_name>
    <arm_group_label>Airmax</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients with nasal obstruction due to external nasal valve problems and with positive
        Cottle sign.

        Age &gt; 18 and &lt; 60 years. Ability to give reliable information and written informed consent.

        Exclusion Criteria:

        Patients with nasal obstruction due to other endonasal anatomic deformities besides
        external nasal valve dysfunction.

        Patients with rhinosinusitis and/or nasal polyps evaluated by nasal endoscopy. Patients
        with chronic lower airway disease like severe asthma, chronic obstructive pulmonary disease
        (COPD), bronchiectasis and/or other conditions that interfere with the generation of a
        reliable Peak Nasal Inspiratory Flow (PNIF) result.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Hellings, Prof Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>UZ Leuven</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Peter Hellings, Prof Dr</last_name>
    <phone>+321632338</phone>
    <email>peter.hellings@uzleuven.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <state>Vlaams-Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emily Dekimpe, Msc</last_name>
      <phone>+3216340757</phone>
      <email>emily.dekimpe@uzleuven.be</email>
    </contact>
    <investigator>
      <last_name>Peter Hellings, Prof Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 17, 2014</study_first_submitted>
  <study_first_submitted_qc>July 21, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2014</study_first_posted>
  <last_update_submitted>December 2, 2015</last_update_submitted>
  <last_update_submitted_qc>December 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

